人免疫缺陷病毒患者巨细胞病毒感染继发的吞噬细胞综合征

Elizabeth Castro*, María Cepeda, Diego Ospina
委内瑞拉马拉开波祖利亚大学医学院

摘要

吞噬血细胞综合征（HPS）或吞噬血淋巴细胞增多症的特征是免疫系统失调，巨噬细胞和 T 淋巴细胞活化，
这是对不同刺激的不可控和过度炎症反应的产物。本文介绍了一例在当前治疗下有人类免疫缺陷病毒（HIV）病史的
患者，其临床表现为发热、厌食和乏力，身体检查皮肤黏膜苍白、脱水、全身性淋巴结病、肝脾肿大。进行了临床
旁试验，表明巨细胞病毒（CMV）再次激活感染，此外，在其住院期间，发现明显的全血细胞减少症，铁蛋白值升高，
进行骨髓活检，观察组织细胞增殖，患者符合组织细胞学会 2004 年提出的 HPS 诊断标准，治疗开始了，但它呈现
出迟钝的演变，最终导致死亡。结论：HPS 诊断复杂；它通常与潜在疾病重叠，这是 CMV 感染再激活的 HIV 患者
的情况；这两种病毒本身都与 HPS 有关；因此，了解该实体的临床和实验室标准对于早期诊断和及时治疗至关重要，
从而降低死亡率。

关键词

噬血细胞综合征；噬血细胞淋巴瘤；巨细胞病毒；人类免疫缺陷病毒

参考

[1] Scott RB., & Robb-Smith AH. (1939). Histiocytic

Medullary Reticulocytosis. The Lancet, 234: 194-198.

[2] Chung C., Estripeaut D., Rodriguez H & Rios C.

(2010). Hemophagocytic syndrome associated with acute

infection by Cytomegalovirus. Presentation of Clinical Case.

Pediatrics Panama, 39 (2): 33-38.

[3] Warley F., Bonella B., Odstrcil-Bobillo M., Otero

V., Waisma G., Bendelman G., Giunta D., Peuchot V., &

Ungaro C. (2017). Clinical characteristics and mortality of

adult patients with hemaphagocytic syndrome, retrospective

cohort study. Rev Med Chile, 145 (3): 344-350.

[4] Pereira L., Dabezies A., Cuturi B., Fernández A.,

& Pérez W. (2018). Hemophagocytic lymphohistiocytosis.

About a case. Archives of Pediatrics of Uruguay, 89 (2):

122-128.

[5] Iscano N., & Fajardo F. (2018). Hemophagocytic

syndrome. J. Med. Hondur., 86 (3 and 4): 134-137.

[6] Egües C., Calvo J., Cabrera L., Sola A., Furundarena

J., Alcorta N., Valero J., López L., Cancio J., Maiz O.,

Uriarte E., & Belzunegui J. (2020). Clinical characteristics

and prognostic factors in patients with Hemophagocytic

syndrome. Int. J. Rare Dis Disorder, 3 (020).

[7] Dávila D, & Peña IR. (2019). Hemophagocytic

syndrome. Case report and literature review. Journal of the

Faculty of Medicine of the UNAM, 62 (2): 15-21.

[8] Rosemberg M., Echavarría G., Ludueña A., Estrada

G., & Molina M. (2018). Hemophagocytosis Secondary to

Dengue. Medicine, 78 (1): 37-40.

[9] Santos L., Martínez O., & Milian G. (2017).

Hemophagocytic syndrome. Case report and disease review.

Medical Certificate of the Center, 11 (4): 38-45.

[10] Li J., Wang Q., Zheng W., Ma J., Zhang W., Wang

W., & Tian X. (2014). Hemophagocytic Linfohistiocytosis.

Analysis clinical of 103 adult patients. Medicine, 93 (2):

100-105.

[11] Espinosa K., García P., Fossas D., & León E.

(2013). Hemophagocytic syndrome. Current concepts.

Medical Gazette of Mexico, 149: 431-7.

[12] Parikh S. Kapoor P., Letendre L., Kumar S., &

Wolansky A. (2014). Prognostic factors and outcomes in

adults with hemophagocytic lymphohistiocytosis. May Clin.

Proc, 89 (4): 484-492.

[13] Guijarro S. (2018). Hemophagocytic syndrome in

a patient with acquired immunodeficiency syndrome: a case

study. Therapeia 10: 145-150.

[14] Dos Santos G., Uría R., Silvera L., Santos C.,

Oliver C., Frantchez V., Cichero M., Solari P., Grille S., Sosa

L., & Silvariño R. (2017). Hemophagocytic syndrome: a rare

complication in the patient with human immunodeficiency

virus (HIV) infection. Uruguayan Journal of Internal

Medicine, 2 (1): 25-31.

[15] Rivière S., Galicier L., Coppo P., Marzac C.,

Aumont C., Lambotte O., & Fardet L. (2014). Reactive

Hemophagocytic Syndrome in Adults: A Multicenter

Retrospective Analysis of 162 Patients. The American

Journal of Medicine, 127 (11): 1118-1125.